Computational modelling and molecular dynamics simulations of a cyclic peptide mimotope of the CD52 antigen complexed with CAMPATH-1H antibody

Molecular Simulation

Volumn 36, Issue 2, 2010, Pages 127-137

  Stavrakoudis, Athanassios ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

turn; Antigen antibody interactions; CAMPATH 1H; CD52 antigen; Computer simulation; Disulphide cyclisation; Molecular dynamics; QSAR

Indexed keywords

BOUND STATE; CAMPATH-1H; CD52 ANTIGEN; COMPUTATIONAL MODELLING; CONFIGURATIONAL ENTROPY; CYCLIC PEPTIDES; CYCLISATIONS; CYS RESIDUES; DISULPHIDE BONDS; EXPLICIT WATER; FREE STATE; HYDROGEN BOND INTERACTION; MOLECULAR DYNAMICS SIMULATIONS; SIDE CHAINS; STRUCTURAL SIMILARITY; SURFACE AREA;

ANTIBODIES; ANTIGENS; COMPUTATIONAL METHODS; COMPUTER SIMULATION; CYCLIZATION; DYNAMICS; HYDROGEN BONDS; MOLECULAR DYNAMICS; POLYPEPTIDES;

PEPTIDES;

EID: 77049127796     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927020903124593     Document Type: Article

References (50)

1. E.J. Sundberg and R.A. Mariuzza, Molecular recognition in antibody-antigen complexes, Adv. Protein Chem. 61 (2002), pp. 119-160.
2. R.M. MacCallum, A.C. Martin, and J.M. Thornton, Antibody- antigen interactions: Contact analysis and binding site topography, J. Mol. Biol. 262 (1996), pp. 732-745.
3. D. Nagorsen and E. Thiel, Monoclonal antibodies in clinical hematology and oncology, Curr. Opin. Invest. Drugs 8 (2007), pp. 996-1001.
4. M. Jain, N. Kamal, and S.K. Batra, Engineering antibodies for clinical applications, Trends Biotechnol. 25 (2007), pp. 307-316.
5. W. Shi, C. Qu, and Q. Qian, Trends in therapeutic monoclonal antibodies of cancer, Expert Opin. Ther. Pat. 17 (2007), pp. 1047-1059.
6. X.Y. Liu, L.M. Pop, and E.S. Vitetta, Engineering therapeutic monoclonal antibodies, Immunol. Rev. 222 (2008), pp. 9-27.
7. J.C. Almagro and J. Fransson, Humanization of antibodies, Front. Biosci. 13 (2008), pp. 1619-1633.
8. A. Domagala and M. Kurpisz, CD52 antigen - a review, Med. Sci. Monit. 7 (2001), pp. 325-331.
9. F.J. Dumont, CAMPATH (alemtuzumab) for the treatment of chronic lymphocytic leukemia and beyond, Expert Rev. Anticancer Ther. 2 (2002), pp. 23-35.
10. R.L. Schmouder, Immunosuppressive therapies for the twenty-first century, Transplant. Proc. 32 (2000), pp. 1463-1467.
11. L.C. James, G. Hale, H. Waldmann, and A.C. Bloomer, 1.9A ° structure of the therapeutic antibody CAMPATH-1H fab in complex with a synthetic peptide antigen, J. Mol. Biol. 289 (1999), pp. 293-301.
12. V.A. Tatsis, I.G. Tsoulos, and A. Stavrakoudis, Molecular dynamics simulations of the TSSPSAD peptide antigen in free and bound with CAMPATH-1H Fab antibody states: The importance of the b-turn conformation, Int. J. Pept. Res. Ther. 15 (2009), pp. 1-7.
13. K.S. Kee and S.D. Jois, Design of beta-turn based therapeutic agents, Curr. Pharm. Des. 9 (2003), pp. 1209-1224.
14. A. Gupta, H.W. Van Vlijmen, and J. Singh, A classification of disulfide patterns and its relationship to protein structure and function, Protein Sci. 13 (2004), pp. 2045-2058.
15. A.S. Galanis, F. Albericio, and M. Grotli, Enhanced microwaveassisted method for on-bead disulfide bond formation: Synthesis of alpha-conotoxin MII, Biopolymers 92 (2009), pp. 23-34.
16. A. Stavrakoudis, G. Bizos, D. Eleftheriadis, A. Kouki, E. Panou- Pomonis,M. Sakarellos-Daitsiotis, C. Sakarellos, D. Tsoukatos, and V. Tsikaris, A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: Design, synthesis, and structure-function relationships, Biopolymers 56 (2000), pp. 20-26.
17. A. Stavrakoudis and V. Tsikaris, Computational studies on the backbone-dependent side chain orientation induced by the (S,S)- CXC motif, J. Pept. Sci. 14 (2008), pp. 1259-1270.
18. J. Chatterjee, D.F. Mierke, and H. Kessler, Conformational preference and potential templates of N-methylated cyclic pentaalanine peptides, Chemistry 14 (2008), pp. 1508-1517.
19. M. Heller, M. Sukopp, N. Tsomaia, M. John, D.F. Mierke, B. Reif, and H. Kessler, The conformation of cyclo(-D-Pro-Ala4-) as a model for cyclic pentapeptides of the DL4 type, J. Am. Chem. Soc. 128 (2006), pp. 13806-13814.
20. W.F. van Gunsteren, J. Dolenc, and A.E. Mark, Molecular simulation as an aid to experimentalists, Curr. Opin. Struct. Biol. 18 (2008), pp. 149-153.
21. M. Karplus and J.A. McCammon, Molecular dynamics simulations of biomolecules, Natl Struct. Biol. 9 (2002), pp. 646-652.
22. W.F. van Gunsteren and H.J.C. Berendsen, Computer simulation of molecular dynamics: Methodology, applications, and perspectives in chemistry, Agnew. Chem. Int. Ed. Engl. 29 (1990), pp. 992-1023.
23. T. Hansson, C. Oostenbrink, and W.F. van Gunsteren, Molecular dynamics simulations, Curr. Opin. Struct. Biol. 12 (2002), pp. 190-196.
24. S. Voordijk, T. Hansson, D. Hilvert, and W.F. van Gunsteren, Molecular dynamics simulations highlight mobile regions in proteins: a novel suggestion for converting a murine V(H) domain into a more tractable species, J. Mol. Biol. 300 (2000), pp. 963-973.
25. B. Lorenzo, F. Duccio, P. Francesco, R. Paolo De Los, S. Michel, and S. Ulf, A dynamical study of antibody-antigen encounter reactions, Phys. Biol. 4 (2007), pp. 172-180.
26. V. Lafont, M. Schaefer, R.H. Stote, D. Altschuh, and A. Dejaegere, Protein-protein recognition and interaction hot spots in an antigen-antibody complex: Free energy decomposition identifies "efficient amino acids", Proteins Struct. Funct. Bioinform. 67 (2007), pp. 418-434.
27. V.A. Tatsis, A. Stavrakoudis, and I.N. Demetropoulos, Molecular dynamics as a pattern recognition tool: An automated process detects peptides that preserve the 3D arrangement of Trypsin's Active Site, Biophys. Chem. 133 (2008), pp. 36-44.
28. A. Stavrakoudis, S. Makropoulou, V. Tsikaris, M. Sakarellos- Daitsiotis, C. Sakarellos, and I.N. Demetropoulos, Computational screening of branched cyclic peptide motifs as potential enzyme mimetics, J. Pept. Sci. 9 (2003), pp. 145-155.
29. A. Stavrakoudis, A disulfide linked model of the complement protein C8g complexed with C8a indel peptide, J. Mol. Mod. 15 (2009), pp. 165-171.
30. Y. Duan and P.A. Kollman, Pathways to a protein folding intermediate observed in a 1-microsecond simulation in aqueous solution, Science 282 (1998), pp. 740-744.
31. W. Humphrey, A. Dalke, and K. Schulten, VMD visual: Molecular dynamics, J. Mol. Graph. 14 (1996), pp. 33-38.
32. A.D. MacKerell, D. Bashford, M. Bellott, R.L. Dunbrack, J.D. Evanseck, M.J. Field, S. Fischer, J. Gao, H. Guo, S. Ha, D. Joseph-McCarthy, L. Kuchnir, K. Kuczera, F.T.K. Lau, C. Mattos, S. Michnick, T. Ngo, D.T. Nguyen, B. Prodhom, W.E. Reiher, B. Roux, M. Schlenkrich, J.C. Smith, R. Stote, J. Straub, M. Watanabe, J. Wiorkiewicz-Kuczera, D. Yin, and M. Karplus, All-atom empirical potential for molecular modeling and dynamics studies of proteins, J. Phys. Chem. B 102 (1998), pp. 3586-3616.
33. W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, and M.L. Klein, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys. 79 (1983), pp. 926-935.
34. W. Weber, P.H. Hünenberger, and J.A. McCammon, Molecular dynamics simulations of a polyalanine octapeptide under Ewald boundary conditions: Influence of artificial periodicity on peptide conformation, J. Phys. Chem. B 104 (2000), pp. 3668-3675.
35. J.C. Phillips, R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid, E. Villa, C. Chipot, R.D. Skeel, L. Kale, and K. Schulten, Scalable molecular dynamics with NAMD, J. Comput. Chem. 26 (2005), pp. 1781-1802.
36. T. Darden, D. York, and L. Pedersen, Particle mesh Ewald: An N•log(N) method for Ewald sums in large systems, J. Chem. Phys. 98 (1993), pp. 10089-10092.
37. J.P. Ryckaert, G. Ciccotti, and H.J.C. Berendsen, Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes, J. Comput. Phys. 23 (1977), pp. 327-341.
38. S.E. Feller, Y.H. Zhang, R.W. Pastor, and B.R. Brooks, Constant pressure molecular dymanics simulation: The Langevin Piston method, J. Chem. Phys. 103 (1995), pp. 4613-4621.
39. N.M. Glykos, Carma: A molecular dynamics analysis program, J. Comput. Chem. 27 (2006), pp. 1765-1768.
40. I.G. Tsoulos and A. Stavrakoudis, eucb: a C++ program for trajectory analysis, http://stavrakoudis.econ.uoi.gr/eucb (2009).
41. R. Döker, T. Maurer, W. Kremer, K. Neidig, and H.R. Kalbitzer, Determination of mean and standard deviation of dihedral angles, Biochem. Biophys. Res. Commun. 257 (1999), pp. 348-350.
42. D. Frishman and P. Argos, Knowledge-based protein secondary structure assignment, Proteins 23 (1995), pp. 566-579.
43. W. Delano, The PYMOL Molecular Graphics System, Delano Scientific, San Carlos, CA, 2002.
44. S.J. Hubbard and J.M. Thornton, NACCESS. Department of Biochemistry and Molecular Biology, University College London, Thornton, 1993.
45. J. Schlitter, Estimation of absolute and relative entropies of macromolecules using the covariance-matrix, Chem. Phys. Lett. 215 (1993), pp. 487-496.
46. S.T. Hsu, C. Peter, W.F. Van Gunsteren, and A.M. Bonvin, Entropy calculation of HIV-1 Env gp120, its receptor cd4, and their complex: An analysis of configurational entropy changes upon complexation, Biophys. J. 88 (2005), pp. 15-24.
47. T.S.G. Olsson, M.A. Williams, W.R. Pitt, and J.E. Ladbury, The thermodynamics of protein-ligand interaction and solvation: Insights for ligand design, J. Mol. Biol. 384 (2008), pp. 1002-1017.
48. N.C. Singha, N. Surolia, and A. Surolia, On the relationship of thermodynamic parameters with the burried surface area in protein-ligand complex formation, Biosci. Rep. 16 (1996), pp. 1-10.
49. E.J. Sundberg, M. Urrutia, B.C. Braden, B. Isern, D. Tsuchiya, B.A. Fields, E.L. Malchiodi, J. Tormo, F.P. Schwarz, and R.A. Mariuzza, Estimation of the hydrophobic effect in an antigen-antibody protein-protein interface, Biochemistry 39 (2000), pp. 15375-15387.
50. M. Novotny, M. Seibert, and G.J. Kleywegt, On the precision of calculated solvent-accessible surface areas, Acta Crystallogr. D D63 (2007), pp. 270-274.